|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 11-18 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 452K 427K 388K 726K 49.76M 729K 5.1M 1.97M 25.31M 1.95M 1.91M 81.4M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19.2M 18.12M 16.46M 30.84M 2.11B 30.98M 217M 83.7M 1.08B 82.82M 80.98M 3.46B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.04% | +3.26% | +25.58% | +45.13% | 400.19B | |
| Weighted average by Cap. | -0.04% | +3.09% | +35.12% | +61.45% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.42M 1.34M 1.21M 2.28M 156M 2.29M 15.99M 6.18M 79.33M 6.11M 5.98M 255M | 2.38M 2.08M 1.96M 1.78M 3.34M 229M 3.35M 23.44M 9.05M 116M 8.96M 8.76M 374M |
| Net income | -9.14M -7.96M -7.51M -6.83M -12.79M -877M -12.85M -89.86M -34.71M -446M -34.34M -33.58M -1.43B | -8.02M -6.98M -6.59M -5.98M -11.21M -769M -11.26M -78.78M -30.43M -391M -30.11M -29.44M -1.26B |
| Net Debt | 17.85M 15.54M 14.67M 13.33M 24.97M 1.71B 25.09M 175M 67.78M 871M 67.06M 65.57M 2.8B | 21.53M 18.74M 17.69M 16.08M 30.11M 2.06B 30.25M 212M 81.73M 1.05B 80.87M 79.07M 3.38B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
